Number of items: 3.
Using serum CA125 to assess the activity of potential cytostatic agents in ovarian cancer. (2014)
M.R. Hall,
A. Petruckevitch,
Joanna Pascoe,
Mojca Persic,
Saad Tahir,
J.S. Morgan,
Charlie Gourley,
N.S.A. Stuart,
S.M. Crawford,
D.E. Kornbrot,
Wendi Qian
and
G.J.S. Rustin
Detection of disease change from a biological marker : using CA125 in ovarian cancer as an example. (2012)
Wendi Qian,
Marcia Hall,
Gordon J. Rustin
and
Diana Kornbrot
Detection of disease change using a biological marker and clinical application: CA125 in ovarian cancer patients. (2012)
Wendi Qian,
Marcia Hall,
Gordon J. Rustin
and
Diana Kornbrot
This list was generated on Wed Oct 21 01:52:19 2026 BST.